CMS advises Grünhorn Group on acquisition of majority stake by HEAL Group
Leipzig – HEAL is acquiring a majority stake in one of Germany's leading suppliers of medical cannabis. As a result, Grünhorn has secured a strategic majority shareholder with a long-term focus for the next phase of its corporate development. The acquisition is intended to further strengthen Grünhorn's strong market position and drive additional growth. It gives Grünhorn access to a larger procurement and partner network as well as additional opportunities to further develop its product portfolio and existing platform.
The Grünhorn Group operates an integrated business model, including such elements as the online pharmacy specialising in medical cannabis; Schurer Pharma & Kosmetik GmbH, a provider of automated fulfilment and logistics services for pharmacies stocking cannabis; canymed GmbH, a pharmaceutical wholesaler and manufacturer of medical cannabis products; and the digital service platform CanDoc for telemedicine services. Continuity of the existing range of products is maintained for customers and prescribers.
HEAL is a privately held, global healthcare and health tech group with operational presence in Canada, the US, the UK and Germany. HEAL is already active in the German medical cannabis market through Khiron. HEAL invests in, develops and acquires companies across the healthcare sector. Its focus is on integrated solutions that connect patients, healthcare providers and pharmacies. As a strategic shareholder with a long-term focus, HEAL brings to bear not only international healthcare expertise but in particular existing market knowledge in Germany, experience in establishing and scaling healthcare companies and an international network.
A CMS team led by Dr Jörg Lips provided comprehensive legal advice to the Grünhorn Group on the transaction and the associated expansion of its position in the German market. The advice covered in particular structuring and negotiating the transaction as well as matters relating to company law, competition law, tax law, IP and IT law and litigation. The transaction was characterised in particular by the specific regulatory features of the cannabis sector.
Press contact
[email protected]
